Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF790 antisense RNA 1 (ZNF790-AS1) is a human long noncoding antisense RNA transcribed from the ZNF790 locus. It is classified as “non-protein coding” and acts in cis or trans to modulate gene expression, often by affecting local chromatin structure, transcription factor recruitment, or mediating transcriptional interference. Antisense lncRNAs are thought to play important regulatory roles in cellular processes such as gene silencing and activation, chromatin remodeling, and imprinting; however, there is currently no direct functional data or disease association published for ZNF790-AS1 itself[1][3]. It is formally annotated in genome databases (HGNC, Ensembl) but remains a poorly characterized, putatively regulatory noncoding RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF790 antisense RNA 1 (ZNF790-AS1).